L. Chaput et al. / Journal of Molecular Catalysis B: Enzymatic 76 (2012) 29–36
35
Fig. 3. Tetrahedral intermediate (TI) and side chains orientation of butan-2-ol and pentan-2-ol enantiomers. S enantiomer in green and R enantiomer in orange. The white
arrow points out the stereospecificity pocket.
4.5. Conclusions
enantioselectivity through differences in energetic pathways
between enantiomers. This is a first attempt to quantify free energy
difference using the FEP method to study CALB enantioselectiv-
ity. In the future this could become a very interesting tool for the
pharmaceutical industry.
Experimental data obtained with enantiopure butan-2-ol shows
that enantiopreference of CALB for the R form arises mainly from
a lower apparent KM and, to a much lesser extent, from a higher
kcat for this enantiomer. With pentan-2-ol, enantiopreference arises
from both a lower KM and a much higher kcat for the R enantiomer,
suggesting that no general rule can be defined for all substrates,
as far as the contribution of the various kinetic parameters to
enantioselectivity is concerned. FEP calculations presented in this
study successfully provided qualitative prediction of the enantio-
preference of CALB for R enantiomers in the case of four of the five
substrates tested. However, the quantitative prediction of the enan-
tiomeric ratio itself proved challenging. In the best cases, namely,
butan-2-ol and pentan-2-ol, the corresponding free energy dif-
ference was overestimated by 0.2–0.3 kcal mol−1, on average. For
hexan-3-ol, only one trajectory amongst the three which were per-
formed, gave almost the same result as the experimental result.
This corresponds also to the only case where a small shift of
the ˛-helix 10 occurs, and this is certainly a case where a bet-
ter accommodation of the enzyme occurred. On the whole, FEP
calculations provide a much more efficient evaluation of energy
difference between enantiomers than potential energy evaluation.
Differences in absolute values between calculated and experimen-
tal ꢀꢀG‡ may be attributed to the limitations of our approach for
modelling global enzyme accommodation, including, for example,
the possible movement of the ˛-helix 10 which may allow CALB to
adapt the shape of its active site to large substrates like hexan-3-ol.
We are fully aware of the fact that the protocol can be improved,
in order to give a better reproducibility and enabling at the same
time, a global enzyme accommodation during simulation. Another
sition state of the reaction as a tetrahedral intermediate. In this
respect, QM/MM calculations may prove useful, to better define
both the geometry of the transition state and the distribution of
charges around the chiral centre and also perhaps including a few
key neighbouring amino acid residues [51–53]. Notwithstanding,
FEP calculations can provide results for novel substrates, without
the need for a significant number of experimental data to adjust
the model, as is the case, for instance, with 3D-QSAR methods.
Moreover, FEP calculations can provide clues about tetrahedral
intermediate geometries. Indeed, the analysis of the trajectories
performed during this study strongly supports Haeffners model of
the orientation of the S substrates within the active site of CALB:
the S orientation was preserved in all cases, except that of pentan-
2-ol. The data presented here help in understanding the origin of
Acknowledgements
This study was supported by the French ANR (National Research
Agency) through the EXPENANTIO project (program CP2D). CINES
and IDRIS from GENCI (Grand Equipement National de Calcul
Intensif) are acknowledged for giving access to super-computing
facilities. The manuscript was corrected by a native English scien-
References
[1] R.D. Schmid, R. Verger, Angew. Chem. Int. Ed. 37 (1998) 1608–1633.
[2] M.T. Reetz, Curr. Opin. Chem. Biol. 6 (2002) 145–150.
[3] R.J. Kazlauskas, A.N.E. Weissfloch, A.T. Rappaport, L.A. Cuccia, J. Org. Chem. 56
(1991) 2656–2665.
[4] D. Rotticci, F. Haeffner, C. Orrenius, T. Norin, K. Hult, J. Mol. Catal. B: Enzym. 5
(1998) 267–272.
[5] M.-P. Bousquet-Dubouch, M. Graber, N. Sousa, S. Lamare, M.-D. Legoy, Biochim.
Biophys. Acta 26 (2001) 90–99.
[6] F. Haeffner, T. Norin, K. Hult, Biophys. J. 74 (1998) 1251–1262.
[7] C. Orrenius, F. Haeffner, D. Rotticci, N. Öhrner, T. Norin, K. Hult, Biocatal. Bio-
transform. 16 (1998) 1–15.
[8] F. Haeffner, T. Norin, Chem. Pharm. Bull. 47 (1999) 591–600.
[9] D. Rotticci, J.C. Rotticci-Mulder, S. Denman, T. Norin, K. Hult, ChemBioChem 2
(2001) 766–770.
[10] J. Uppenberg, N. Öhrner, M. Norin, K. Hult, G.J. Kleywegt, S. Patkar, V. Waagen,
T. Anthonsen, J.T. Alwyn, Biochemistry 34 (1995) 16581–16838.
[11] C.H. Kwon, D.Y. Shin, J.H. Lee, K.S. Wook, K.J. Won, J. Microbiol. Biotechnol. 17
(2007) 1098–1105.
[12] C. Orrenius, C. van Heusden, J. van Ruiten, P. Overbeeke, H. Kierkels, J.A. Duine,
A.J. Jongejan, Protein Eng. 11 (1998) 1147–1153.
[13] S. Raza, L. Fransson, K. Hult, Protein Sci. 10 (2001) 329–338.
[14] A. Warshel, G. Naray-Szabo, F. Sussman, J.K. Hwang, Biochemistry 28 (1989)
3629–3637.
[15] H. Eyring, M. Polanyi, Z. Phys. Chem. 12 (1931) 279.
[16] R.S. Philipps, Enzyme Microb. Technol. 14 (1992) 417–419.
[17] R.S. Philipps, Trends Biotechnol. 14 (1996) 13–16.
[18] A.P.L. Overbeeke, C. Orrenius, J.A. Jongejan, J.A. Duine, Chem. Phys. Lipids 93
(1998) 81–93.
[19] J. Ottosson, L. Fransson, K. Hult, Protein Sci. 11 (2002) 1462–1471.
[20] V. Leonard-Nevers, Z. Marton, S. Lamare, K. Hult, M. Graber, J. Mol. Catal. B:
Enzym. 59 (2009) 90–95.
[21] P. Braiuca, K. Lorena, V. Ferrario, C. Ebert, L. Gardossi, Adv. Synth. Catal. 351
(2009) 1293–1302.
[22] T. Schulz, J. Pleiss, R.D. Schmid, Protein Sci. 9 (2000) 1053–1062.
[23] P.B. Juhl, P. Trodler, S. Tyagi, J. Pleiss, BMC Struct. Biol. 9 (2009) 39–55.
[24] E. García-Urdiales, N. Ríos-Lombardía, J. Mangas-Sánchez, V. Gotor-Fernández,
V. Gotor, ChemBioChem 10 (2009) 1830–1838.